Polaris Inc.·4

Jan 30, 8:15 PM ET

Speetzen Michael T 4

4 · Polaris Inc. · Filed Jan 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Polaris (PII) CEO Michael Speetzen Receives Equity Award

What Happened

  • Michael T. Speetzen, CEO of Polaris Inc. (PII), received equity awards on January 28, 2026. The filing reports two components: 65,446 shares acquired at $64.94 per share (total value reported $4,250,063) and a derivative award for 243,275 shares recorded at $0.00.
  • These transactions are grants/awards (transaction code A), not open-market purchases or sales—i.e., compensation-related equity, not an outright stock buy or sale.

Key Details

  • Transaction date: 2026-01-28. Filing date: 2026-01-30 (timely; Form 4 generally must be filed within two business days).
  • Awarded shares: 65,446 shares at $64.94 (reported value $4,250,063). Derivative award: 243,275 shares @ $0.00 (reported as derivative/option).
  • Vesting note (footnote F1): the derivative option vests in three equal installments on Feb 9, 2027; Feb 8, 2028; and Feb 13, 2029.
  • Shares owned after the transaction: not provided in the data you supplied (check the full Form 4 for post-transaction beneficial ownership).
  • No indication in this filing that shares were sold or that a 10b5-1 plan or tax withholding was used.

Context

  • This is a grant of compensation equity (one cash-valued share award and a larger derivative/options award with future vesting). Such grants are common for executives and reflect compensation decisions rather than immediate trading intent.
  • Because the larger portion is a derivative award that vests over time, its economic benefit depends on future vesting and Polaris’s share price at those vesting dates.

Insider Transaction Report

Form 4
Period: 2026-01-28
Transactions
  • Award

    Common Stock

    2026-01-28$64.94/sh+65,446$4,250,063188,117 total
  • Award

    Employee Stock Option (right to buy)

    [F1]
    2026-01-28+243,275243,275 total
    Exercise: $71.43Exp: 2036-01-28Common Stock (243,275 underlying)
Footnotes (1)
  • [F1]The option vests in three equal installments on February 9, 2027, February 8, 2028, and February 13, 2029.
Signature
/s/ Sarah Maveus, as attorney-in-fact|2026-01-30

Documents

1 file
  • 4
    wk-form4_1769822108.xmlPrimary

    FORM 4